This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Dermatology
Dermatology
Is vitamin D status an important biomarker for symptom severity in COVID-19?
View: Should patients with psoriasis stop their biologics because of COVID-19?
Which biologics provide the greatest improvement in moderate-to-severe psoriasis?
Could regular emollient use from birth prevent the development of atopic eczema?
Sunbed use and melanoma – is there really a link?
Interleukins in moderate to severe psoriasis
What next for dupilumab?
Bimekizumab Phase III study meets all endpoints
Dupixent hits endpoints in Phase III paediatric trial
Antibiotics can inhibit skin lymphoma
Review: Tildrakizumab for moderate to severe psoriasis
Janssen submits EMA application for the use of Guselkumab in moderate to severe plaque psoriasis
« Previous
1
…
5
6
7
8
9
…
21
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: